HRD and Resistance to PAPPi in EOC Patients

Clinical trial NCT05310370 · UNKNOWN

Trial details

NCT number: NCT05310370
Sponsor: Lei Li
Status: UNKNOWN
Study type: OBSERVATIONAL

Epithelial Ovarian Cancer Homologous Recombination Deficiency Homologous Recombination Repair Gene Mutation Poly(ADP-ribose) Polymerase Inhibitor Drug Resistance Progression-free Survival Overall Survival

Start date: 2022-03-26
Primary completion: 2024-03-26
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.